ADVANCED PAEDIATRIC CONSCIOUS SEDATION: AN ALTERNATIVE
TO DENTAL GENERAL ANAESTHETIC IN THE UK.
Hand DP1, Averley PA2, Lyne JP3, Girdler NM4.
1Senior House Officer, Department of Child Dental Health, Newcastle Dental Hospital. 2Principal General Dental Practitioner, Queensway Anxiety Management Clinic, Billingham, Teesside. 3Honorary Clinical Lecturer, Department of Sedation, Newcastle Dental Hospital. 4Professor and Honorary Senior Consultant Department of Sedation, Newcastle Dental Hospital.
Paediatric dentistry, Conscious sedation, Midazolam, Sevoflurane, Fentanyl.
Dr. Darren Hand Dept. Paediatric Dentistry Newcastle Dental Hospital Richardson Road Newcastle upon Tyne NE2 4AZ United Kingdom
Child dental anxiety is widespread, and it is not always possible to
treat children using traditional methods such as behavioral management, local
anaesthesia and even relative analgesia. In such cases a dental general anaesthetic
(DGA) is the only option available to facilitate dental treatment in anxious children.
This study describes an advanced conscious sedation protocol which allows
invasive treatment to be carried out in anxious children. It incorporates the use of
titrated intravenous midazolam and fentanyl and inhalation agents, sevoflurane and
nitrous oxide/oxygen, which is administered by a Consultant Anaesthetist. The aim is
to produce an evidence based study which can offer a sedation technique as a safe and
267 clinical records were audited retrospectively from a specialist sedation
based clinic, for children aged between 5-15 years old. The subjects all underwent
invasive dental procedures with this technique between August and November 2008
262/267 (98%) of the subjects were treated safely and successfully and
without the loss of verbal communication using this technique. This included many
treatments requiring four quadrant dentistry, with both restorations and extractions as
necessary being carried out in one visit. 5 subjects (2%) did not tolerate treatment and
had to be referred for a DGA. No medical emergencies occurred.
Based on the evidence for this group of patients, this advanced
conscious sedation technique utilising inhalation sevoflurane and nitrous
oxide/oxygen and intravenous midazolam and fentanyl, offers a safe and effective
alternative to DGA when carried out in a dedicated, specialist environment.
Introduction and Background.
Dental anxiety in children is widespread and the problem of treating extremely
anxious children, other than by a hospital admission for DGA, is an area which has
seen progressive research [Averley et al., 2004a]. Many new techniques researched
include the use of oral and transmucosal benzodiazepines, intravenous propofol,
inhaled sevoflurane, and ketamine, all of which are considered to be acceptable for
anxiety management in children [Averley et al., 2004a; Gilchrist et al., 2007; Hosey,
2002; Mikhael et al., 2007; Millar et al., 2007; Wilson et al., 2006; Wilson et al.,
This audit was carried out at Queensway Anxiety Management Clinic
(QAMC) in Billingham, Cleveland, UK. It is a clinic which provides a unique,
specialist, dental referral centre for children and adults who cannot be managed in
normal general practice with behavioral and local anaesthetic techniques alone.
Treatment here is carried out by a professional team of 12 dentists, each of who have
postgraduate training/qualifications in conscious sedation. This is in conjunction with
six Consultant anaesthetists who provide full-time management and cover for patients,
six days a week. QAMC delivers dental care for more than 8000 children and adults
per year [Averley et al., 2004b], using a range of sedation techniques which are each
specific to the individual and their needs. These techniques range from simple
Relative Analgesia (RA) using inhaled nitrous oxide/oxygen in combination with
local anaesthesia (LA), to a more complex procedure of advanced conscious sedation,
which incorporates inhalation and intravenous techniques.
Dental practitioners who are both appropriately trained and experienced in
conscious sedation assess patients in line with current Standards for Conscious
Sedation in Dentistry guidelines [SDAC, 2003], and the Standards for Conscious
Sedation in Dentistry: Alternative techniques guidance [Standing Committee on
Sedation for Dentistry, 2007]. Following these guidelines, as a first line of
management, inhalation sedation with nitrous oxide (RA) is offered to both adults and
children. If this treatment does not meet the requirement of the individual then adults
and children over 16 years old are offered treatment with intravenous midazolam as a
lone sedative, or with the possibility of additional RA to help decrease their anxiety.
For the more anxious or uncooperative children (generally under 16 years of age)
where experience dictates that they would not be able to tolerate treatment under RA,
or for those who have previously failed RA, then these children are offered an
alternative to DGA and are invited to be treated using advanced conscious sedation
techniques. Express written consent is gained and these children are sedated in line
with current guidelines [SDAC, 2003; Standing Committee on Sedation for Dentistry,
2007] and treated using a combination of titrated intravenous midazolam and fentanyl,
with the addition of inhaled sevoflurane (0.3%) and nitrous oxide (40%). These drugs
are administered by a specialist trained consultant anaesthetist in conjunction with a
dedicated team who carry out all necessary dental treatment, generally in one visit.
This audit was implemented to assess the success of the outcomes with this sedation
technique, in the treatment of anxious paediatric dental patients as an alternative
Materials and Methods
The combination of intravenous midazolam and fentanyl is not a new technique for
use in paediatric care in the hospital environment [Mamula and Markowitz, 2004;
Sury, 2004;]. From this concept, an anxiety management technique for treating
paediatric dental patients was developed for use at QAMC by the Consultant
anaesthetists and dental teams, which also included the addition of inhalation
The design of this audit is retrospective and was achieved by extracting quantitative
data from patient record cards and extrapolating it onto data collection sheets over a
three month period commencing from 1st August 2008.
Population and sample
In total, 420 clinical records were inspected between 1st August 2008 and
31st October 2008, producing 267 viable inclusions for the audit. (Table 1)
Inclusion criteria for study data collection:
Children deemed to be ASA (American Society of Anesthesiology)
Children aged 5-15 years old who will agree to sit in the dental chair at
assessment and are able to tolerate an examination.
Children, who when assessed by dentists experienced in the
management of anxious children, were unable to accept treatment
under LA alone or in combination with RA.
Children deemed to have an adequate degree of comprehension and
understanding regarding the treatment (if necessary with the support of
Children deemed to be able to accept breathing through a nasal hood
and able to have EMLA® (lidocaine and prilocaine) topical anaesthetic
cream applied to the dorsum of the hand.
Exclusion criteria for study data collection:
Children ASA III or above for treatment
Children with hypersensitivity to benzodiazepines, sevoflurane, nitrous
Children aged below 5 years old, or 15 years old or above.
Children who had refused the nasal hood, or who would not sit in the
dental chair prior to, or at the start of treatment on the day. This would
have resulted in non-cannulation with no intravenous drugs being
given, and treatment therefore being abandoned.
Children who had failed to attend (FTA) or who had cancelled their
Children who were on their second visit for the same course of
treatment and had experienced fentanyl before.
Children who had no record of drug increments in their clinical notes
The patient is assessed for treatment in line with current sedation guidelines [SDAC,
2003; Standing Committee on Sedation for Dentistry, 2007], which includes a full
medical history and weight measurement. Valid written consent is then gained by the
legal parent/guardian for the treatment of the patient and fasting instructions and
attendance instructions are given both in written form and verbally to the
parent/guardian, who will also be acting as their supervisor. An appointment is made
and topical anaesthetic cream (EMLA® cream) is given to the patient to apply before
their appointment. This cream is applied to the dorsum of the hand an hour before
treatment is due to commence to prevent pain upon intravenous catheter insertion.
Once the patient is in the chair a correctly fitting MATRX M® scavenging nasal hood
is placed on the child and 0.3% sevoflurane and 40% nitrous oxide is inhaled for
approximately two minutes at a flow rate of 6 litres/minute. This is to help settle the
patient’s anxiety and to allow cannulation to take place. After successful cannulation
has been obtained by the anaesthetist, fentanyl is added intravenously (0.5g /kg)
followed by 0.5mg of midazolam per minute. The midazolam is titrated by the
anaesthetist to a clinical end point where the patient is sedated to an appropriate level
to allow treatment to commence. The patient is always able to maintain verbal contact
in accordance to current UK General Dental Council requirements [GDC, 2005].
A Drager- Julian anaesthetic machine, manufactured in 1998, is used to
administer the inhalation sedation agents and also monitor oxygen saturation, blood
pressure and other tracings (see below). The nasal hoods used had been specially
adapted to incorporate a probe to measure fractional inspired and end-tidal, oxygen,
carbon dioxide, nitrous oxide and sevoflurane. The anaesthetist continually monitored
oxygen saturation, heart-rate, blood pressure, capnography, fractional inspired
sevoflurane and end-tidal sevoflurane on a written record sheet. These variables were
recorded every five minutes, along with the increments of drugs and the outcome of
The parameters recorded were: age, weight, sex, drug dosage regime and outcome of
the treatment. A non-successful outcome was deemed as the child having accepted
cannulation and titration of drugs, but being too uncooperative to complete treatment
successfully. If treatment was abandoned at this stage then the procedure was classed
as a failure with an unsuccessful outcome recorded, and the patient referred for a
DGA. All data from the clinical records were recorded onto a data collection sheet
using the patients’ clinical number only to allow for complete confidentiality. Data
were then entered into Microsoft® Excel® spreadsheet for analysis.
The main outcome measurement for the audit was to establish whether the use of this
advanced conscious sedation technique was safe, successful and met without
incidence. Using a Microsoft® Excel® spreadsheet, results were drawn up giving
percentages, means and standard deviations. A Chi-squared test was undertaken to
compare the successful completion of dental treatment using this technique against a
267 children classed by the American Society of Anesthesiology grading for ASA
grades I and II were included in the audit. Amongst these children the gender was
approximately even with 52% being male and 48% being female (Table 2).
The age in years of population treated (Table 2) shows a mean of 8.8 (+/-2.7).
The weight in Kg of the population treated (Table 2) shows a range between
15 – 97, with a mean of 33.4 (+/-15.4).
Intravenous Midazolam dosage.
The mean dosage of intravenous midazolam (mg) given per individual for treatment
Intravenous Fentanyl dosage.
The range of intravenous fentanyl (µg) given to the population (Table 2) is between
12.5 and 85with a mean of 33.2 (+/-13.7).
Primary outcome measures.
The primary outcome measures (Table 3) show that 98% (262/267) of children
successfully completed their treatment with this advanced conscious sedation
Comparison of previous studies.
A comparison of studies carried out at the same centre (table 4) show that 98%
(262/267) of children successfully completed their treatment with the addition of
fentanyl, compared with 93% (249/267) of children with the omission of fentanyl
[Averley et al., 2004a]. This was shown to be statistically significant (P=0.012).
All children included in the audit were responsive to verbal commands once sedated
and throughout the duration of the treatment and during recovery. No child lost
consciousness and no adverse events were encountered during treatment that required
emergency medical intervention or hospitalisation. Of post-operative complications
recorded, three children suffered from post-operative vomiting and were given an
anti-emetic (ondansetron). A further child, who was feeling dizzy and disorientated
after treatment, was reversed with flumazenil to aid recovery. The clinical records
taken showed that all children remained well saturated with no patient falling below
95% oxygen saturation during treatment or in recovery. The children were discharged
to their supervisors once they had satisfactorily completed a series of subjective tests
for recovery and were judged by the anesthetist/dentist to be clinically recovered.
The advanced conscious sedation technique that has been described and analysed in
this study is not in common use in the UK and is not used for every child needing
dental treatment at QAMC. The advanced conscious sedation technique is used once
it has been established that the patient will not accept conventional behavioral with
local anaesthetic or RA for their dental treatment. Without this advanced conscious
sedation technique, the only other option open for treatment of these children is via a
DGA. Subsequently, it is clinically vital to acquire further knowledge about the safety
and success of the conscious sedation techniques used, in order to protect these
patients who may be offered this option for their treatment. It is also important to
ensure that the conscious sedation techniques being developed and being used fit with
current UK guidance on conscious sedation [SDAC, 2003; Standing Committee on
Whilst this audit is necessary to evaluate current practice at QAMC, it cannot
adequately assess the full frequency of possible adverse events which may occur
outside a specialist setting. It is very encouraging however, that the results presented
show clearly that the administration of intravenous fentanyl and midazolam, along
with the gaseous inhalation of sevoflurane and nitrous oxide resulted in a very safe
and comprehensive success rate of treatment in these children, whose only other
option was a DGA. This was statistically more so when compared against a previous
study carried out in the same centre in 2004, using only intravenous midazolam,
sevoflurane and nitrous oxide/oxygen. It also recorded that a high proportion of these
procedures carried out were to address multiple carious lesions, generally in four
quadrants and requiring both extractions and/or restorations. The clinical significance
is that when this technique is delivered in a specialist care setting with the
involvement of consultant anaesthetists and specially trained dental teams, then this
technique is shown to be both safe and effective, while also reducing the dependency
on dental general anaesthesia for children. Following this, it is still important that
further studies and controlled trials are undertaken in order to supplement and support
the results from this audit especially when safety is paramount. Adverse events
4 children out of 267 children treated (1.5%) required the attention of the
consultant anaesthetist during recovery. None of these children ever lost
consciousness or experienced a drop in their oxygen saturation, but it still highlights
that best practice for advanced sedation is one that should be carried out in a dedicated
environment with the necessary collection of training, equipment and personnel to
deal with any medical emergencies that may occur. Subsequently, it is a remit of
QAMC that the whole dental team is efficient and well rehearsed in the management
of medical emergencies with an up-to date emergency protocol which is evidence
based, clear and easy to follow. Therefore it must be mandatory that further
postgraduate training be undertaken to ensure that this advanced sedation technique
remains safe and does not result in the fateful consequences of DGA which occurred
in dental practice. However, there is still a place for DGA in dentistry, as children
are extremely unpredictable and for some, treatment with conscious sedation will still
The evidence from this audit concludes that by adhering strictly to the SDAC
Alternatives Techniques guidance [Standing Committee on Sedation for Dentistry,
2007], advanced paediatric conscious sedation utilizing multiple intravenous and
inhalational sedative agents can, and does work extremely well for patients at QAMC,
and is a very effective and safe alternative to DGA.
Averley PA, Girdler NM, Bond S, Steen N, Steele J. A randomised controlled trial of
paediatric conscious sedation for dental treatment using intravenous
midazolam combined with inhaled nitrous oxide or nitrous oxide/sevoflurane.
Averley PA, Lane I, Sykes J, Girdler NM, Steen N, Bond S. An RCT pilot study of
the effects of intravenous midazolam as a conscious sedation technique for
anxious children requiring dental treatment -an alternative to general
anaesthesia. Br. Dent. J. 2004: 197; 553-8.
Department of Health. A conscious decision. A review of the use of general
anaesthesia and sedation in primary dental care. London: DoH. 2000.
General Dental Council. Standards for Dental Professionals. London: GDC,
Gilchrist F, Cairns AM, Leitch JA. The use of intranasal midazolam in the
treatment of paediatric dental patients. Anaesthesia. 2007; 62:1262-5.
Hosey MT. UK National Clinical Guidelines in Paediatric Dentistry. Int. J.
Mamula P, MarkowitzSafety of intravenous midazolam and fentanyl for
pediatric GI endoscopy. J. Pediatr. Gastroenterol. Nutr. 2004; 39:S359.
Millar K, Asbury A, Bowman AW, Hosey MT, Martin K, Musiello T,
Welbury RR. A randomised placebo-controlled trial of the effects of
midazolam premedication on children's postoperative cognition. Anaesthesia.
Mikhael MS, Wray S, Robb ND. Intravenous conscious sedation in children
for outpatient dentistry. Br. Dent. J. 2007; 203:323-31.
Standards for Conscious Sedation in Dentistry: Alternative Techniques. A Report
from the Standing Committee on Sedation for Dentistry 2007.
Standing Dental Advisory Committee. Conscious Sedation in the Provision of Dental
Care: Report of an expert group on sedation for dentistry. DoH.2003.
Sury MRJ. Paediatric sedation. Continuing Education in Anaesthesia, Critical
Wilson KE, Girdler NM, Welbury RR. A comparison of oral midazolam and nitrous
oxide sedation for dental extractions in childre2006; 61: 1138-
Wilson KE, Welbury RR, Girdler NM. Comparison of transmucosal midazolam with
inhalation sedation for dental extractions in children. A randomised, cross-
Exclusions for Audit
Table 1: Total number of clinical records inspected and the percentage of
Primary Outcome Measurements
Table 2: Summary of results for audit population.
Comparison of Success Rate Treatment Outcome
Table 3. Success rate of completion of treatment for audit population.
Comparison of Success Rate
Primary Outcome of Group Cross tabulation
Chi square the difference between groups was significantly different at 5% level:
Table 4: Comparison of success rate of completion of treatment between 2004
(without fentanyl) and 2007 (with fentanyl) sedation technique studies.
Background Information Roche Personalised Healthcare – In Brief Background Personalised Healthcare is based on the knowledge that different patients with the same clinical diagnosis may respond to the same treatment in different ways. While a certain drug might be highly effective for one patient, the same drug might not show the same desired results in another patient, despite
Evaluate the Effectiveness of Fluoxetine 90mg Administered Every Week and Every 2 Weeks in Nursing Home Residents Terrance Bellnier, RPh, MPA, Shyam Karki, PharmD, MA, Tulio Ortega, MD, Adam Decatur, PharmD, Department of Pharmacy Practice ABSTRACT: PMH 6 Cost Data RESULTS: Effectiveness data DISCUSSION Purpose: To evaluate the effectiveness of fluoxetine 90mg every week/every 2 we